{
  "actions": [
    {
      "acted_at": "2018-12-18",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2018-12-18",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3770-115",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "115",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2018-12-18",
  "number": "3770",
  "official_title": "A bill to amend title XI of the Social Security Act to expand the scope of transparency reporting requirements related to the ownership or investment interests of health care providers and others, and to increase the penalties associated with violating such requirements.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Medicaid Drug Decisions Transparency Act",
  "sponsor": {
    "bioguide_id": "B001288",
    "district": null,
    "name": "Booker, Cory A.",
    "state": "NJ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2018-12-18",
  "subjects": [
    "Business investment and capital",
    "Business records",
    "Government information and archives",
    "Health",
    "Health personnel",
    "Health technology, devices, supplies",
    "Medicaid",
    "Medical ethics",
    "Medicare"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2018-12-18",
    "date": "2019-09-03T22:07:27Z",
    "text": "Medicaid Drug Decisions Transparency Act\n\nThis bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests to include pharmacists and individuals with authority over Medicaid formularies, and also increases civil penalties for violations."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicaid Drug Decisions Transparency Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend title XI of the Social Security Act to expand the scope of transparency reporting requirements related to the ownership or investment interests of health care providers and others, and to increase the penalties associated with violating such requirements.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Medicaid Drug Decisions Transparency Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:40:39Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s3770.xml"
}